
Moss Genomics Inc. — Investor Relations & Filings
Moss Genomics Inc. is a biotechnology company specializing in genomics and microbiome research, dedicated to developing advanced genetic insights and personalized health solutions. The company's core offering is a blockchain-based platform designed for the private, secure storage and monetization of individual genomic data. Recent corporate strategy has emphasized significant integration with digital assets, positioning the company as a hybrid entity. This strategy includes substantial investments in Ethereum (ETH) and participation in cryptocurrency mining operations, such as Bitcoin Cash (BCH), alongside its consumer genomics initiatives.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 52-109FV2 - Certification of interim filings - CEO (E).pdf | 2026-03-02 | English | |
| Interim MD&A - English.pdf | 2026-03-02 | English | |
| Interim financial statements/report – English.pdf | 2026-03-02 | English | |
| News release - English.pdf | 2026-01-05 | English | |
| 52-109FV2 - Certification of interim filings - CFO (E).pdf | 2025-12-02 | English | |
| Interim MD&A - English.pdf | 2025-12-01 | English |
Browse filings by year
5 yearsMarket data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
OncoTherapy Science, Inc.
Biopharmaceutical company researching and developing novel …
|
4564 | JP | Professional, scientific and te… |
|
Optipharm.CO.,LTD
Develops animal health solutions, biotherapeutics, and xeno…
|
153710 | KR | Professional, scientific and te… |
|
ORAGENICS INC
Biotechnology company developing intranasal therapeutics fo…
|
OGEN | US | Professional, scientific and te… |
|
ORGANOIDSCIENCES LTD.
Develops organoid-based technologies for drug development a…
|
476040 | KR | Professional, scientific and te… |
|
Orum Therapeutics, Inc.
Clinical-stage biotech developing degrader-antibody conjuga…
|
475830 | KR | Professional, scientific and te… |
|
OSR Holdings, Inc.
A healthcare holding company acquiring and developing innov…
|
OSRH | US | Professional, scientific and te… |
|
OS Therapies Inc
Clinical-stage immunotherapy company developing treatments …
|
OSTX | US | Professional, scientific and te… |
|
Ovation Science Inc.
Develops and licenses patented Invisicare® technology for e…
|
OVAT | CA | Professional, scientific and te… |
|
OXFORD BIODYNAMICS PLC
Develops and commercializes precision medicine tests for on…
|
OBD | GB | Professional, scientific and te… |
|
Oxurion NV
Acquires majority stakes in European pharmaceutical subcont…
|
OXUR | BE | Professional, scientific and te… |
Moss Genomics Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/48378/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=48378 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=48378 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=48378 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 48378}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Moss Genomics Inc. (id: 48378)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.